Letter: Oral contraceptives, plasma-lysolecithin, and platelet aggregation.
D045166:Estradiol Congeners / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008244:Lysophosphatidylcholines / Q000097:blood*; D010743:Phospholipids / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects*; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000494:pharmacology*
D045166:Estradiol Congeners; D008244:Lysophosphatidylcholines; D010743:Phospholipids; D045167:Progesterone Congeners